Salute e Benessere

Labviva Announces Global Expansion, Appoints General Manager of Europe

Leading life sciences technology company to accelerate adoption of automated procurement and supplier diversity worldwide BOSTON and LONDON, May15, 2025(GLOBE NEWSWIRE) -- Tariffs, trade barriers, and fragmented regulatory environments are disrupting the global supply chain and threatening the life sciences industry worldwide. That's why Labviva , the leading AI procurement platform for life sciences, today announced its entry into Europe, establishing an international headquarters in...
Nasdaq GlobeNewswire
15/05/2025

Bridge to Life Announces Abstract Presentations at The 2025 International…

Abstracts to be presented: Abstracts to be presented: Late Breaker :Impact of Machine Perfusion on Ischemia-Reperfusion Injury in Liver Transplantation: A Donor Age-Stratified Analysis,Marco Maria Pascale,Francesco Frongillo,Giorgia Selvaggi,Giuseppe Bianco,Anna Caltabellotta,Erida Nure,Salvatore Agnes, Policlinico Universitario Fondazione Agostino Gemelli,Rome, Italy Late Breaker :Machine Perfusion in Liver Transplantation: A Game Changer for Middle-Volume...
PR Newswire
15/05/2025

Philips Future Health Index 2025: AI poised to transform global healthcare…

May 15, 2025 AI has the power to cut care delays and manage data overload, but trust gaps among clinicians and patients threaten to slow adoption and impactAmsterdam, the Netherlands –Royal Philips(NYSE: PHG, AEX: PHIA), a global leader in health technology,has released its 10th annual Future Health Index (FHI) report, highlighting the growing strain on global healthcare systems. The FHI 2025 Report, the largest global survey of its kind analyzing key concerns of healthcare...
Nasdaq GlobeNewswire
15/05/2025

Eisai projects Leqembi® revenue to total JPY 76.5 billion for fiscal year 2025…

BioArctic's report for the first quarter 2025 will be published on May 21 at 08.00 a.m. CET. BioArctic's report for the first quarter 2025 will be published onMay 21at08.00 a.m. CET. This information is information that BioArctic AB (publ) is obliged to disclose pursuant to the EU Market Abuse Regulation. The information was released for public disclosure, through the agency of the contact person below, onMay 15, 2025, at06:00 CET. For further information, please contact:...
PR Newswire
15/05/2025

STEERLife Redefines Potent Drug Development with Clean, Green, Continuous…

At the core of this advancement is STEERLife's proprietary solvent-free melt fusion technology, a continuous processing system that eliminates the need for harmful organic solvents. Designed to precisely handle high-potency and hard-to-develop molecules, this platform significantly enhances formulation efficiency, safety, and scalability. At the core of this advancement is STEER Life 's proprietary solvent-free melt fusion technology, a continuous processing system that eliminates the need...
PR Newswire
15/05/2025

Positive EMA Opinion on Pediatric Investigation Plan for PolTREG's Treg Therapy…

Positive EMA Opinion on Pediatric Investigation Plan for PolTREG's Treg Therapy in Type 1 Diabetes The Paediatric Committee (PDCO) of the European Medicines Agency issues positive opinion on PolTREG's Pediatric Investigation Plan (PIP) for PTG-007 in pre-symptomatic type 1 diabetes (Stage 1).Positive opinion paves the way for potential marketing authorization in the EU and EEA.Recommendation to expand pediatric indication to ages 3–18 years (originally 6–16...
Nasdaq GlobeNewswire
15/05/2025

Inside information: Sarah van Hellenberg Hubar-Fisher appointed interim CEO of…

Van Hellenberg Hubar-Fisher will continue as a member of the company's Board of Directors and as a member of the Board's Audit Committee in addition to her role as the CEO. As a result of van Hellenberg Hubar-Fisher's appointment, the Board of Directors has decided to transfer the duties the Board's Remuneration Committee to the Board of Directors until further notice. Van Hellenberg Hubar-Fisherwill continue as a member of the company's Board of Directors and as a member of the Board's...
PR Newswire
15/05/2025

Antser CEO Named Finalist in Top UK Entrepreneur Awards

Richard founded Antser Group with a mission shaped by his own lived experience. Under his leadership, the organisation has grown significantly, combining clinical expertise, digital innovation, and deep sector insight to drive meaningful improvements for organisations across the UK – all with the goal of achieving better outcomes for vulnerable children, adults, families and communities. Richard founded Antser Group with a mission shaped by his own lived experience. Under his leadership, the...
PR Newswire
15/05/2025

Guelph General Hospital adds digital pathology to cloud service from…

Guelph General Hospital will complement their use of microscopes with a digital solution, allowing the pathologists to enhance review and collaboration around cases as well as benefit from AI tools. The digital workflow provides instant and, when needed, remote access to digital images of tissue samples instead of relying on physical glass slides reviewed in microscopes. With their pathologists and radiologists now sharing a unified system, it will pave the way for integrated diagnostics, which…
PR Newswire
15/05/2025

Aino Health AB (publ): interim report january-march 2025

This document in English is a translation of the original in Swedish. In case of any discrepancy, the Swedish original will prevail. Increased turnover. Positive cashflow. Positive EBITDA.January – March 2024 Turnover totalled 7 378 (5 994) TSEKProfit after financial items -554 (-2 943) TSEK Earnings per share -0,0 (-0,0) SEK The first quarter of 2025 has been characterised by a continued challenging market environment, shaped by cautious investment appetite and continued...
Nasdaq GlobeNewswire
15/05/2025

AB Science today reports a new publication in the scientific journal PLOS One…

PRESS RELEASEMASITINIB SHOWS PROMISING NEUROPROTECTIVE EFFECTS IN NEUROIMMUNE-DRIVEN NEURODEGENERATIVE DISEASE MODEL A NEW PUBLICATION IN THE SCIENTIFIC JOURNALPLOS ONE,SHOWS THAT MASITINIB CAN LOWER SERUM NEUROFILAMENT LIGHT CHAIN, AN IMPORTANT BIOMARKER FOR NEURODEGENERATIVE DISORDERS, INCLUDING MULTIPLE SCLEROSIS, AMYOTROPHIC LATERAL SCLEROSIS AND ALZHEIMER'S DISEASEParis, May 15, 2025, 8am CETAB Science SA(Euronext - FR0010557264 - AB) today announced publication...
Nasdaq GlobeNewswire
15/05/2025

Bioretec Ltd´s business review Q1 2025: Strong net sales in the first quarter…

January - March 2025 in brief January -March 2025in brief This business review is unaudited. Key figures Key events in the reporting period CHAIR OF THE BOARD'S COMMENTS Ramping up for sustainable growth The first quarter of 2025 marked a pivotal phase in our commercialization journey, setting the stage for accelerated global growth. High volume orders fromChinacontributed significantly to topline performance, reflecting both customer confidence and our...
PR Newswire
15/05/2025

CROSSJECT's ZENEO® needle-free autoinjector consistently matches depth of…

Press ReleaseCROSSJECT's ZENEO® needle-free auto-injector consistently matches depth of traditional intramuscular injections and exceeds the standards needle length of currently utilized auto-injectorsInjection depth with ZENEO® matches that of 30-mm conventional intramuscular needles, out-performs length of needles imbedded in commercially available needle-based auto-injectors.ZENEO® further demonstrates commercial adoption potential by eliminating usage errors and mimicking...
Nasdaq GlobeNewswire
15/05/2025

Tutors International Reports Rise in Educational Support Requests Amid US Family…

Tutors International, which provides tailored academic support for relocating families, notes three core concerns: Tutors International, which provides tailored academic support for relocating families, notes three core concerns: Adam Caller, CEO and Founder of Tutors International, comments: "Educational continuity is often the most complex and under-discussed part of moving a family internationally. We've seen more US families opting to relocate toEuropeor the UK in the past...
PR Newswire
15/05/2025

Akeso's Penpulimab Approval Intensifies the Competition Among the Other…

Due to their location and extent of spread, nasopharyngeal cancers are often not suitable for surgical removal. These cancers are usually managed with a combination of chemotherapy and radiation therapy, often followed by additional chemotherapy. If the cancer recurs, it may be treated with another round of radiation, frequently using brachytherapy. In carefully selected cases, skull base resection may be considered as an alternative to radiation. Due to their location and extent of spread,...
PR Newswire
14/05/2025

GENFIT: Publication of the 2025 Extra-Financial Performance Report (fiscal year…

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 14, 2025- GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced the publication of its 2025 Extra-Financial Performance Report (fiscal year 2024).Since 2022, GENFIT has published a detailed Extra-Financial Performance report in response to the growing interest of institutional and individual...
Nasdaq GlobeNewswire
14/05/2025

Galapagos Announces Oral Presentations at EHA and ICML 2025 Featuring Promising…

Mechelen, Belgium; May 14, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG), a global biotechnology company dedicated to transforming patient outcomes through life-changing science and innovation, today announced that new data from our ongoing ATALANTA-1 Phase 1/2 study of GLPG5101 in relapsed/refractory non-Hodgkin lymphoma (R/R NHL) have been accepted for oral presentations at the 2025 European Hematology Association (EHA) Congress taking place June 12-15, 2025, in Milan, Italy,...
Nasdaq GlobeNewswire
14/05/2025

Roche receives FDA approval for the VENTANA MET (SP44) RxDx Assay as the first…

The VENTANA MET (SP44) RxDx Assay detects the MET (also known as c-Met) protein, which is over-expressed in some patients with non-squamous non-small cell lung cancer (NSQ-NSCLC).The MET protein serves as a predictive biomarker for the likelihood of a patient's response to c-Met-targeted therapy. 1 As the leader in companion diagnostics, Roche's broad CDx portfolio helps enable informed clinical decisions and improved patient outcomes. Basel, 14 May 2025 - Roche (SIX: RO, ROG;...
Nasdaq GlobeNewswire
14/05/2025

Piramal Pharma Limited Announces Results for Q4 and FY2025

Key Highlights for Q4FY25/FY25 Nandini Piramal, Chairperson, Piramal Pharma Limitedsaid, " FY25 has been a steady year for the company as we crossed$1Bnin revenues with 12% YoY growth accompanied by 17% EBITDA margin and 5x increase in Net Profits, in-line with our annual guidance. We also managed to maintain our Net Debt / EBITDA level below 3x, while making regular investments in capabilities and capacities for future growth. During the year, we progressed well on our...
PR Newswire
14/05/2025

Increased fatigue may signal hidden nutrient deficiencies, say Nature's Best…

The World Health Organisation advises the most common deficiencies worldwide are iron, vitamin A, and iodine. The World Health Organisationadvises the most common deficiencies worldwide are iron, vitamin A, and iodine. However,vitamin Dis the most prevalent deficiency in the UK, with 1 in 6 adults reported to have low levels. Other fatigue-linked deficiencies include: Vitamin B12– helps produce red blood cells and maintain nerve function. A deficiency can cause tiredness,...
PR Newswire
14/05/2025

Press release: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER…

SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 14 May 2025 – Sequana Medical NV(Euronext Brussels: SEQUA)(the " Company " or " SequanaMedical "), a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart failure and cancer, announces today that in the context of contributions in kind of certain receivables (for an aggregate amount of EUR 1,018,105.00) due under the convertible loan agreement entered into…
Nasdaq GlobeNewswire
14/05/2025

RAMSAY SANTE : Interim results at the end of March 2025

PRESS RELEASE Paris, 14 thMay 2025 Interim results at the end of March 2025Activity growth and cost control compensate pricing headwinds Unaudited group revenue for the nine months period ending 31 March 2025 increased by 5.1% to 3.9bn€ supported by activity volume growth and Cosem primary care centres acquired in June 2024. Revenue growth of 3.2% on a like-for-like basis.Unaudited group EBITDA for the nine months period ending 31 March 2025 was almost...
Nasdaq GlobeNewswire
14/05/2025

AI In Diagnostics Market to Hit $5.44 Billion by 2030 at CAGR 22.46% - Grand…

Request a free sample copy or view report summary: Artificial Intelligence In Diagnostics Market Request a free sample copy or view report summary:Artificial Intelligence In Diagnostics Market The growing burden of chronic conditions across the global population is also driving the demand for AI-based diagnostic solutions. The key participants in AI in diagnostics market are focusing on the development of new, innovative products and the expansion of their business offerings to gain a...
PR Newswire
14/05/2025

Radiation, Detection, Monitoring & Safety Market worth US$5,452.4 million by…

Browse in-depth TOC on "Radiation, Detection, Monitoring & Safety Market" Browse in-depth TOC on "Radiation, Detection, Monitoring & Safety Market" 348 - Tables52 - Figures310 - Pages By Based on product,the radiation, detection, monitoring & safety market is segmented into radiation detection and monitoring systems, material monitors, and radiation monitoring software. The radiation detection and monitoring systems segment dominates the market share and...
PR Newswire
14/05/2025
Altri  Comunicati